BUFIX | RERGX | BUFIX / RERGX | |
Total Expense Ratio | 1.05 | 0.47 | 223% |
Annual Report Gross Expense Ratio | 1.05 | 0.47 | 223% |
Fund Existence | 18 years | 16 years | - |
Gain YTD | 12.725 | 11.113 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 902M | 132B | 1% |
Annual Yield % from dividends | 0.77 | 1.45 | 53% |
Returns for 1 year | 5.31 | 1.40 | 380% |
Returns for 3 years | 26.30 | 19.09 | 138% |
Returns for 5 years | 57.82 | 31.59 | 183% |
Returns for 10 years | 94.58 | 21.15 | 447% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DULL | 4.13 | 0.12 | +2.99% |
MicroSectors™ Gold -3X Inverse Lvrgd ETN | |||
IBTH | 22.36 | 0.01 | +0.07% |
iShares iBonds Dec 2027 Term Tr ETF | |||
DFEB | 43.11 | N/A | N/A |
FT Vest US Equity Deep Bffr ETF Feb | |||
UAUG | 35.72 | -0.02 | -0.07% |
Innovator U.S. Equity Ultra BufferETFAug | |||
BIB | 43.10 | -0.28 | -0.65% |
ProShares Ultra Nasdaq Biotechnology |